Imamov Olim Abdilxodjaevich

Dr. Imamov is a medical oncologist with 25 years of clinical experience in thoracic oncology, chemotherapy, targeted therapy and immunotherapy. Since 2018 he has headed the organizational and methodological department of the Cancer Prevention Center, coordinating nationwide telemedicine consultations and regional outreach visits by leading specialists, and he teaches oncology at Tashkent State Medical University.

MD, 1st Tashkent State Medical Institute (2001). Candidate of Medical Sciences (PhD equivalent), Republican Oncology Research Center (2007). Primary specialization in General Oncology (2008) and Chemotherapy (2015), Tashkent Institute of Postgraduate Medical Education. International fellowships: Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, South Korea (2009–2010); Medical Oncology (chemotherapy, immunotherapy and targeted therapy), Pitié-Salpêtrière Hospital, Paris, France (2010); advanced training in drug therapy of malignant tumors, National Medical Research Radiological Centre, Ministry of Health of Russia (2019).

Board certification in General Oncology (2008) and Chemotherapy (2015), Tashkent Institute of Postgraduate Medical Education; certified fellowship in Thoracic and Cardiovascular Surgery, Seoul National University Bundang Hospital, South Korea (2009–2010); certified training in Medical Oncology, Pitié-Salpêtrière Hospital, Paris, France (2010); Highest Qualification Category in Chemotherapy (Certificate No. AA013921, National Chamber of Innovative Healthcare, 2022; valid through 2027).

Author of more than 20 scientific publications and 6 clinical guidelines; recipient of the Ministry of Health's "Best Doctor" award (2008); assistant lecturer in Oncology, Oncohematology and Radiation Oncology at Tashkent State Medical University (since 2025; previously at Tashkent Pediatric Medical Institute, 2022–2025).